A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease
Phase: PHASE1 | Sponsor: Jennifer Mitchell | Compound: Psychedelic
- Status
- recruiting
- Institution
- Jennifer Mitchell
- Start date
- 2026-03-01
- End date
- 2030-02-01
- Registry ID
- NCT07386730
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.